AUB Flashcards

1
Q

Adenomyosis MUSA criteria (8)

A

asymmetrical thickening
fan-shaped shadowing
translesional vascularity
irregular junctional zone
myometrial cysts
hyperechoic islands
echogenic subendometrial lines and buds
interrupted junctional zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

changes AUB classification 1

A

1) frequency: amenorrhea included
2) duration: normal 8 and below
3): frequency: 24-38
4) regularity: normal cycle interval is <7-9 days, irregular >8-10 days
5) HMB NIH definition of disrupts QOL
6) included if intermenstrual scheduled/cyclic or random
7) included if breakthrough bleeding while on pills/meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COIEN changes

A

medication under iatrogenic
n = not otherwise classified including isthmocele and av malformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

chronic aub

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PALM changes

A

MUSA criteria for adeno
AUB-L: type 3 is SM
0 vs 1, 6 vs 7 –> pedicle has to be 10% of mass diameter
2 vs 3: need hystero with minimal visualization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AUB-C criteria

A

1) heavy menses since menarche
2) one of the following:
postpartum hemorrhage
surgical related bleeding
bleeding associated with dental work
3) two or more:
bruising 1-2x/month
epistaxis 1-2x/month
frequent gum bleeding
fam hx of bleeding sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

menses MOA

A

progesterone withdrawal > destabilizes lysososme membrane > release of MMPs, acid phosphatase > enzymatic degradation of functionalis layer

progesterone withdrawal > release of inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

end of menses MOA

A

vasoconstriction in the denuded spiral arterioles in the basal layer of the endometrium and also possibly in the radial arteries of the superficial myometrium.

mediated by prostaglandins esp PGF2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

estrogen withdrawal bleeding

A

as in those post BSO or estrogen only pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

estrogen breakthrough bleeding

A

as in PCOS or those with chronic anovulation/unopposed estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

progesterone withdrawal

A

ex as in progestin challenge test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

progesterone breakthrough bleeding

A

ex those on dienogest or DMPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA anovulatory bleeding

A

patchy endometrial growth but no dominant follicle - Em proliferates and outgrows blood supply = fragile EM > bleed and regrow patchy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA AUB myoma (8)

A

increased surface area
uterine venous ectasia
fragile and engorged vessels
impaired platelet action
increase in TGFB3
molecular changes (VEGF, MMP, bFGF)
impaired myometrial contractility
impaired vasoconstriction

10
Q

von Willebrand disease

A

vWf needed for platelet action and hemostasis
most common cause of coagulopathy

10
Q

LABS

A

pregnancy test
CBC, blood typing
Iron studies
crea, bun, AST, ALT
PT/PTT
TV-UTZ
TSH, PRL
estradiol, LH, FSH
papsmear
EM bx
mammography (if applicable)

11
Q

Acute Heavy Menses (Anovulatory)

Requirement: thickened EM to suggest estrogen exposure

A

High dose progestin x 7-10 days then OD x 3 weeks
MPA 10-20mg BID
Megace 20-40mg BID
NETA 5mg BID

12
Q

E-P regimens (20-25mcg)

A

4 pills x 1 week
3 pills x 1 week
2 pills x 1 week
1 pill x 1 week
stop
1 pill x 1 week

12
Q

Maintenance AUB (Anovulatory)

A

OCP
Cyclic Progestin (like MPA 5-10 mg OD 10-14days per month)
DMPA 150mg q3months
LNG-IUS

12
Q

E-P (30-35mcg)

A

QID x 4 days
TID x 3 days
BID x 2 days
OD x 3 weeks

13
Q

progestin MOA antiestrogen

A

1) inc 17BHSD and sulfotransferase to convert E2 to E3 and be rapidly cleared
2) inhibit induction of estrogen receptor
3) inhibit transcription of oncogenes

13
Q

Acute HMB with THIN EM

A

CEE 25mg IVq4 x 24 hours
then 2.5mg PO q6 or micronized estradiol 2mg OD until bleeding stops then taper to OD, add a progestin for 7-10 days

consider switching to OCP after

13
Q

Adjuncts to AUB

A

anti-fibrinolytic
Tranexamic Acid 1g IV q8 or 500mg 2tabs q8

NSAIDs
Ibuprofen 400mg TID
Mefenamic Acid 500mg TID

14
Q

Pregnancy risk of Myoma

A
  • PTB
  • Malpres
  • RPL
  • Hemorrhage
  • Previa
  • Dysfunctional labor
  • IUGR
  • IUFD
15
Q
A
16
Q
A
17
Q
A
18
Q
A